Morinaga Hokuriku Milk, a subsidiary of Morinaga Milk Industry, announced that it will invest approximately ¥2 billion to expand the facilities at its Fukui Plant. Production capacity for bifidobacteria and lactic acid bacteria powders is expected to increase by approximately 30% across the group, with operations targeted to begin in January 2029.
Morinaga Milk Industry announced a plan by its subsidiary, Morinaga Hokuriku Milk, to expand the facilities at its Fukui Plant in Fukui. The expansion investment will amount to approximately ¥2 billion and is intended to expand the production structure against a backdrop of growth in the microbial business.
The investment is expected to increase group-wide production capacity for bifidobacteria and lactic acid bacteria powders by approximately 30%, with a substantial increase in annual output anticipated in the future. Construction is scheduled to begin during the month, and operations are scheduled to start in January 2029.
Once operational, annual production capacity across the group is expected to reach approximately 250 tonnes. Morinaga Milk Industry positions the microbial business as a growth area. Sales have increased approximately threefold over the past 8 years, and further growth is expected.